On Friday, the FDA approved the Teal Wand, the first at-home test for cervical cancer screening, developed by Teal Health. Traditionally, cervical cancer screening involves uncomfortable pelvic exams, deterring some women from getting tested. Dr. Emeline Aviki, a gynecologic oncologist, noted that many patients avoid pelvic exams, which could contribute to the fact that a significant number of women are not up to date on their screenings. Despite cervical cancer being highly preventable through screenings and HPV vaccinations, screening rates have decreased since the mid-2000s, with 23% of women behind on screenings as of 2019.
The Teal Wand works by detecting HPV through a self-collected vaginal swab, making it less invasive than traditional pap smears. HPV is the primary cause of cervical cancer, and while there’s no direct treatment for the virus, most cases resolve spontaneously. Dr. George Sawaya highlighted that this at-home test could significantly increase accessibility for women, especially those in rural areas, given that they face a greater risk of cervical cancer due to lower access to healthcare.
Patients will order the Teal Wand after a telehealth consultation, collect their samples at home, and send them to a lab for analysis. Positive results will lead to further medical care arranged by Teal Health. However, concerns remain regarding the test’s cost and if patients will follow up for necessary treatment. Although the price has not yet been disclosed, Teal Health expects the test may be covered by insurance due to its endorsement by the U.S. Preventive Services Task Force. Experts like Dr. Jessica Kiley still stress the importance of regular gynecological visits for comprehensive care.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
